ABRAXIS HEALTH

Pharmaceutical preparations for the treatment of critical illnesses, namely, cancer, Alzheimer's disease, central nervous systems disorders, auto-immune disorders and transplant rejections; Diagnostic preparations for medical purposes

software and hardware for the integration of health data from patients, providers and payers

Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare

research and development of next generation diagnostics and therapeutics tailored to specific molecular profiling of patient tissues and treatments for critical illnesses; electronic data collection and data submission services for developing, testing and validating next-generation diagnostics and pharmaceuticals to target pre-selected patients based on molecular profiles to predict drug response to particular therapeutics; computerized electronic data integration services, namely, providing an interactive database that integrates patient data, bioinformatics, discovery research, molecular medicine, and clinical developments in order to match patients with their personalized treatment regimens and preferred healthcare providers